Is Anthropic Worth $1.5 Trillion? Both Sides Make Their Case

Is Anthropic Worth $1.5 Trillion? Both Sides Make Their Case

Anthropic is now a public company, and its first day of trading gave both sides of the argument something to point to. The Claude developer priced its offering at $83 a share on November 18, above the $70 to $78 range it had marketed, and sold 980 million shares to raise $81.3 billion, the largest initial public offering on record. When the stock began trading on the Nasdaq the next day under the ticker ANT, the first trade came at $111.50, and shares rose as high as $114.99 before giving back much of the gain. They closed at $97.17, up about 17% from the offering price, on a day when the record listing couldn’t stop a broader market slide.

At $83 a share, Anthropic was valued at about $1.51 trillion on a fully diluted basis, a count that includes unvested employee options and other promised shares. The first close put it near $1.77 trillion on the same basis, by AktieGo’s calculation.

Bulls see a company whose revenue rose more than tenfold in a year and whose stock cleared a raised price with room to spare. Bears see a valuation that leaves little room for error, a compute bill many times larger than its cash, and a share structure that keeps public investors far from control.

$83 In, $97 Out

The Deal and the Debut, November 18-19, 2026
$83 In, $97 Out
Where ANT priced, opened, peaked and closed on its first day
$60 $80 $100 $120 Marketed range $70-$78 $83 IPO price First close $97.17 $111.50 First trade Day high $114.99
$81.3B
Raised
980 million shares at $83; largest IPO on record
980M
Shares Sold
Up from 825 million in the November 10 roadshow terms
$26.0B
Nonvoting Class N shares at the IPO price; Google and Nvidia $10B each
$1.51T
Value at $83
Fully diluted, including unvested options and other promised shares
~$1.77T
Value at Close
Same fully diluted basis, scaled to the $97.17 close (AktieGo calc)
+17%
Day One
Close vs. offer price; first trade was about 34% above it
Sources: CNN (Nov 18, 2026); CBC News (Nov 18 and 19, 2026); Reuters via WINK News and Forbes (Nov 19, 2026); Anthropic roadshow announcement and Form S-1/A (Nov 10, 2026). Dashed outline = marketed range, not a trade.

Anthropic sold more stock than it first planned. Its roadshow announcement on November 10 offered 825 million shares, about 801.4 million from the company and 23.6 million from existing holders, at $70 to $78. Demand pushed the final count to 980 million and the price above the top of the range. Alongside the public sale, the company arranged a $26.0 billion private placement of nonvoting Class N shares at the offering price with Google, Nvidia, AMD, Broadcom, Micron, Microsoft and TSMC Partners. Google and Nvidia account for $10 billion each.

The drop from the $111.50 open to the $97.17 close is the first thing each side reads differently. The offering price is set before trading begins, while the open is simply the first trade on the exchange, so investors who were allocated shares at $83 ended the day well ahead and anyone who bought at the open did not. CBC described a session in which investors weighed enthusiasm for AI against the size of the valuation and an uncertain path to profit.

A 1,127% Year

Revenue vs. Compute Cost, US$ Billions
A 1,127% Year
Reported figures from Anthropic’s amended S-1
Revenue Compute and infrastructure 2024 Full year $0.4B $2.5B 2025 Full year $4.6B $7.3B 9M 2025 Jan-Sep $2.5B $4.4B 9M 2026 Jan-Sep $33.2B $18.8B
$17.0B
Q3 2026 Revenue
Up 1,127% from a year earlier; compute expense up 382%
57%
Compute vs. Revenue
Nine months of 2026, down from about 172% a year earlier (AktieGo calc)
$1.3B
Operating Loss
Nine months of 2026, down from $5.2B a year earlier
Source: Anthropic, PBC Form S-1/A, Amendment No. 2 (Nov 10, 2026), summary financial data. All figures reported (solid). Ratios are AktieGo calculations from the filing.

The bull case starts with revenue. Anthropic reported $17.0 billion in revenue for the three months ended September 30, up 1,127% from a year earlier. Over the first nine months of 2026 it booked $33.2 billion, against $2.5 billion in the same stretch of 2025 and $4.6 billion for all of last year.

Costs grew too, just more slowly. Compute and infrastructure, the company’s biggest expense, rose 382% in the third quarter. Over nine months it came to $18.8 billion, about 57% of revenue, down from about 172% of revenue a year earlier, by AktieGo’s calculation from the filing. The operating loss shrank from $5.2 billion to $1.3 billion over the same two periods.

Anthropic also reports an adjusted operating figure that shows a $4.1 billion profit for those nine months. That is a non-GAAP measure, which leaves out some costs, and the filing reconciles it to the reported numbers. Skeptics give it little weight. NYU finance professor Aswath Damodaran wrote in October that the adjusted profits rest on “a patchwork of add-backs.”

The $104 Billion Loss That Isn’t What It Looks Like

The headline loss is enormous: $104.0 billion for the first nine months of 2026. Almost all of it, $94.3 billion, came from a change in the fair value of convertible notes, SAFEs and related instruments, which the filing says was driven mainly by the rising value of its outstanding convertible promissory notes. As Anthropic’s valuation climbed, the notes that convert into its shares became worth more on paper, and accounting rules book that increase as a loss. It is not cash leaving the company.

That doesn’t make the business profitable. Take out the paper charge and Anthropic still ran an operating loss.

The $900 Billion Bill

What Anthropic Owes vs. What It Has, US$ Billions
The $900 Billion Bill
White = commitments; amber = cash on hand and new money raised
Compute commitments Total, as of Sept 30 $900.9B Due before end-2030 Expected $451.6B Due within 12 months From Sept 30 $70.7B Cash + short-term inv. Sept 30, pre-IPO $131.9B IPO gross proceeds 980M shares at $83 $81.3B Private placement Class N, at IPO price $26.0B
$6.2B
Debt
Total indebtedness as of September 30, 2026
~25%
Top Five Customers
Share of revenue, first nine months of 2026; none above 10%
2030
Cash Flow Turns Positive
Goldman Sachs projection, as reported by the Financial Times
Sources: Anthropic, PBC Form S-1/A, Amendment No. 2 (Nov 10, 2026); CNN (Nov 18, 2026) for IPO proceeds; Financial Times via Newsquawk (Nov 10, 2026) for the Goldman projection. Cash plus short-term investments ($95.6B + $36.3B) is an AktieGo sum. Dashed outline = bank projection.

The bear case starts here. Anthropic has signed about $900.9 billion of compute and infrastructure commitments, with about $451.6 billion expected before the end of 2030 and about $70.7 billion due within 12 months of September 30. Against that, it held $95.6 billion in cash and $36.3 billion in short-term investments at the end of September, before any IPO money arrived, and carried $6.2 billion of debt.

The filing flags that some of the cloud providers and suppliers it depends on are also investors and customers, which creates potential conflicts of interest. Several of the same chip and cloud companies are buying stock in the private placement. Bulls read that as suppliers backing their customer with their own money. Bears see money moving in a circle.

Revenue has its own concentration. No customer made up more than 10% of revenue in the first nine months, but the top five accounted for about 25%, and sales through cloud providers’ marketplaces were 44%.

Even the lead bank’s model shows a long wait for cash. Goldman Sachs, which led the offering with Morgan Stanley, projects that Anthropic won’t turn free cash flow positive until 2030, when it expects $33.6 billion, the Financial Times reported. Those are bank projections relayed by people familiar with them, not company figures.

Who Really Runs It

Share Classes and Voting Power
Who Really Runs It
Anthropic is a public benefit corporation; its board must weigh other interests alongside shareholder returns
Class
Held by
Voting
Other terms
Class A
Public investors and other holders
One vote per share
Trades on Nasdaq as ANT
Class N
Mainly strategic partners
No vote, except as required by law
Converts to Class A on transfer to an unaffiliated party
Class T
Long-Term Benefit Trust (one share)
Elects the Class T directors, a board majority
No economic rights
Class F
Founder LLC (one share)
50.1% of total voting power on general matters
No economic rights
Class E
Employees, excluding co-founders
Limited voting on certain matters
No economic rights
Source: Anthropic, PBC Form S-1/A, Amendment No. 2 (Nov 10, 2026). The trust has five trustees and no authority over day-to-day management. The prospectus lists this structure as a risk that may limit Class A holders’ influence, including over a change of control.

A Class A share, the stock that trades as ANT, carries one vote and very little say. Anthropic is a public benefit corporation, so its board must balance shareholder returns against the interests of others affected by the company. Control sits in two places. A single Class F share held by a founder LLC carries 50.1% of the total voting power on general matters. A single Class T share held by the Long-Term Benefit Trust, whose five trustees are meant to be financially disinterested, elects the directors who will make up a majority of the board. Class N shares, held mainly by strategic partners, have no vote except where the law requires one.

The trust agreement filed with the prospectus says the trust exists to make sure the company balances shareholders’ financial interests with the interests of people affected by its conduct and the responsible development of advanced AI. The prospectus also lists the structure as a risk, saying it may limit Class A holders’ influence, including over a change of control. Damodaran is more pointed. In his November 18 update, he called the founder share “far more powerful” than the golden shares some governments keep in privatized companies.

Two Readings of the Same Debut

Is Anthropic Worth $1.5 Trillion?
Two Readings of the Same Debut
▲
The Bull Case
Hypergrowth
Q3 2026 revenue of $17.0B, up 1,127% from a year earlier
Costs falling behind
Compute was 57% of revenue in the first nine months of 2026, from about 172%
Street targets
Needham $150, Melius $155 (two-year), New Street $105; William Blair Outperform
Partners buying in
Google and Nvidia put $10B each into the private placement
▼
The Bear Case
Value below price
Damodaran (Nov 18): about $1.35T, or about $76 a share, vs. the $83 offer
The compute bill
About $900.9B of commitments vs. $131.9B of cash and short-term investments
Cash comes late
Goldman Sachs projects positive free cash flow only in 2030 (FT)
Deep skeptic
New Constructs’ lowest scenario: as little as $144B (Oct 6, before the public filing)
Neither case is a forecast or a recommendation. Sources: Anthropic Form S-1/A (Nov 10, 2026); Invezz, Investing.com, Yahoo Finance (November 2026); Aswath Damodaran, Musings on Markets (Nov 18, 2026); Financial Times via Newsquawk (Nov 10, 2026); The Next Web (Oct 16, 2026).

The Bull Case

The first published research came from firms outside the underwriting group, and it was positive. Needham analyst Scott Berg started coverage with a Buy rating and a $150 price target, which values Anthropic at 18 times estimated fiscal 2027 revenue, and he outlined a $200 bull case, arguing Anthropic can become a dominant platform alongside Amazon, Alphabet and Microsoft. Melius Research started at Buy with a two-year target of $155. New Street Research’s Pierre Ferragu called it a “generational IPO” and set a $105 target before the final price was known, and William Blair’s Arjun Bhatia judged the valuation reasonable for its growth, below the peer median on estimated 2027 sales. Before pricing, Morningstar saw 24% upside from the $74 midpoint of the range, forecasting 47% annual revenue growth from 2027 to 2031.

The bulls’ other evidence is the trend inside the filing. Revenue is growing far faster than compute costs, the operating loss is shrinking, and partners including Google and Nvidia put $10 billion each into the private placement.

The Bear Case

Damodaran published his own estimate of Anthropic’s value the day it priced. His November 18 update puts equity value at about $1.35 trillion, or about $76 a share on an option-adjusted basis, below the $83 offering price, after he lowered his margin and capital-efficiency assumptions. Earlier in the month he had it at about $1.45 trillion. He has also said the biggest single uncertainty in his model is whether revenue reaches $1 trillion within a decade.

New Constructs, an independent research firm, went much further in an October 6 report, calling the listing “an unprecedented test of investor gullibility.” Under its lowest scenario, Anthropic’s equity could be worth as little as $144 billion, with a middle scenario at $1.1 trillion. That report predates the public filing and was aimed at a then-rumored $2 trillion valuation.

The rest of the bear case is the material above: $900.9 billion of commitments, an operating loss, a lead bank that doesn’t see positive free cash flow until 2030, and a share structure that limits public holders. Even William Blair, for all its optimism, said investors had more questions than answers about competition and falling model prices.

Where They Meet

Baillie Gifford’s Peter Singlehurst told CNBC that Anthropic’s long-term success will depend less on its IPO-day valuation than on whether it keeps building frontier models, keeps revenue growing fast and becomes profitable, Benzinga reported. Both camps would sign that sentence. They disagree on how likely that is, and on how much of it the price already assumes.

$76 or $155? Take Your Pick

Published Per-Share Targets and Estimates, US$
$76 or $155? Take Your Pick
Dashed circles = targets or estimates; solid lines = actual prices
IPO price $83 First close $97.17 Aswath Damodaran Value estimate, Nov 18 $76 New Street Research Buy, set before pricing $105 Needham Buy, Nov 19 $150 Melius Research Buy, two-year target $155 $60 $80 $100 $120 $140 $160
Sources: Aswath Damodaran, Musings on Markets (Nov 18, 2026, option-adjusted value per share); Yahoo Finance (New Street); Invezz (Needham, Nov 19, 2026); Investing.com (Melius, Nov 19, 2026). New Constructs published no per-share figure and is not plotted. None of these firms appears among the underwriters listed in the Nov 10 filing. Not a recommendation.

The published figures so far run from about $76 to $155 a share, against an $83 offering price and a $97.17 first close. The three highest are price targets from firms that started coverage with Buy ratings. Damodaran’s $76 is his estimate of value, not a trading target, and New Constructs did not publish a per-share figure, so it isn’t plotted.

None of the firms behind these figures appears among the underwriters listed in the November 10 filing, by AktieGo’s check. Research from the banks that ran the deal usually follows only after a post-IPO quiet period. Until then, the spread is wide, and early.

Five Things to Watch

Forward Indicators, November 2026
Five Things to Watch
1
Index inclusion
FTSE Russell said it will add the stock at the open on December 14, CNBC reported. Nasdaq’s usual 15-day wait for its indexes would normally end December 11; no Nasdaq-100 date has been announced.
2
Research from the underwriters
Goldman Sachs and Morgan Stanley led the deal. Research from the syndicate usually starts after a post-IPO quiet period; no date has been announced.
3
Early lock-up releases
About 3.6 billion shares may become eligible for sale before the 180-day mark. The private placement shares are not locked up at all.
4
First report as a public company
Fourth-quarter and full-year 2026 results; the date has not been announced. The test is whether revenue keeps outrunning compute costs.
5
The 12-month bill
About $70.7 billion of compute and infrastructure commitments fall due within 12 months of September 30.
Sources: CNBC (Nov 18, 2026); Anthropic, PBC Form S-1/A, Amendment No. 2 (Nov 10, 2026). Dates not announced are marked as such. Not a recommendation.

Supply is the near-term variable. About 15.5 billion shares are covered by lock-up or similar agreements, generally for up to 180 days, and up to 365 days for the co-founders and holders of more than 0.5% of the fully diluted shares. About 3.6 billion shares may become eligible for sale before the 180 days end, including up to 10% of the locked-up holdings of employees and other non-founder insiders. The private placement shares are not locked up.

FAQ

Did Anthropic really lose $104 billion?

On paper, for the first nine months of 2026, yes. But $94.3 billion of that came from the rising value of convertible notes and similar instruments as the company’s valuation went up, which is an accounting charge rather than cash spent. Its operating loss over the same period was $1.3 billion.

Is Anthropic worth $1.5 trillion or $2 trillion?

Both numbers circulate because they measure different moments. About $1.51 trillion is the fully diluted value at the $83 offering price. Reports of about $2 trillion or more refer to the first day’s early trading. At the first close, the same fully diluted measure was about $1.77 trillion.

Why did the stock fall back from its opening price?

No single cause was reported. The offering price is set before trading, while the open is the first trade, so the two can differ widely. Coverage of the session described investors weighing AI enthusiasm against the valuation and an uncertain path to profit. Shares still closed about 17% above the offering price.

Do public shareholders control Anthropic?

No. Class A shares carry one vote each, but a single founder share holds 50.1% of voting power on general matters, and the Long-Term Benefit Trust elects a majority of the board. The prospectus lists this structure as a risk for Class A holders.

When can insiders sell?

In stages. Most pre-IPO holders are restricted for up to 180 days, and the co-founders and largest holders for up to 365 days, but about 3.6 billion shares may become eligible earlier, including up to 10% of employee and other non-founder insider holdings. Private placement shares have no lock-up.

Is Anthropic stock a buy?

AktieGo doesn’t recommend securities. The firms that started coverage this week rate it Buy or Outperform, while Damodaran’s estimate of value sits below the offering price and New Constructs’ lowest scenario sits far below it. Which side is right depends largely on whether revenue keeps outrunning compute costs.

Sources

Disclaimer

Sources: Anthropic’s SEC filings and announcements, named analysts and research firms, and wire and financial press as cited. Fully diluted valuation at the close, compute-to-revenue ratios and the underwriter cross-check are AktieGo calculations from the cited figures. Price targets, value estimates and bank projections are forecasts, not results. AktieGo doesn’t independently verify third-party data, so figures should be checked at the time you’re reading this.

These are speculative investments carrying significant risk including potential total loss of capital. Coverage on aktiego.com is provided for informational and educational purposes only. aktiego.com is not a registered investment advisor. Nothing in this article constitutes financial, investment, or professional advice. Readers are encouraged to conduct their own due diligence and consult a qualified financial advisor before making any investment decisions. For more information please see our full DISCLAIMER.

AktieGo

More Market Insights
on YouTube

Watch our latest market briefings, CEO interviews and stock deep dives covering the companies and sectors we follow.

Nvidia's $500 Billion AI Financing Bet
Nvidia’s $500 BILLION AI Financing Bet: Brilliant Move or Hidden Risk?
The Drone Revolution: Why Warfare Has Changed Forever
The Drone Revolution: Why Warfare Has Changed Forever
The AI CyberSecurity Arms Race Has Begun
The AI CyberSecurity Arms Race Has Begun
Market Briefings
3× per week
Stock Deep Dives
In-depth analysis
CEO Interviews
Exclusive insights
Emerging Sectors
Mining · Tech · Energy · Biotech
The AktieGo Brief

The market moves fast.
Our briefing keeps up.

Curated updates on stock picks, company spotlights, and in-depth market analysis across mining, biotech, energy, crypto, and tech — delivered straight to your inbox. Join thousands of investors who start their morning with the AktieGo Brief.



Name

BRIEF